TCF4 and Pitt-Hopkins syndrome: Most mutations leading to PTHS are de novo, with occasional cases of parental mosaicism (Kousoulidou et al., 2013; Steinbusch et al., 2013), resulting in either reduced TCF4 function or dominant negative effects.